Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
abacavir, ABC, ABN, ACD, AcquisitionInc, admitted, agalsidase, AGENERASE, AICPA, AK, alpha, ALZA, ameliorate, Amgen, amortised, amprenavir, AMRO, analog, andestimated, Andrew, anemia, appellate, Appendix, aremoved, arose, art, Article, ascribe, associatedwith, assumption, AstraMerck, atanavir, atransitional, attached, Australian, authoritization, avoided, backup, BASF, beingreleased, benchmark, bioequivalence, Biogen, BLA, black, BMS, borrow, borrowing, bovine, box, bridging, bulk, Cambridge, carcinoma, cardiac, carrier, carryingvalue, categorised, cattle, cent, chance, Chancery, Chapter, characterised, chose, chromosomal, Citigroup, Citizen, CITRIVAN, classification, cleaved, Cola, Columbia, combat, comment, commonplace, complementary, complicated, CONCERTA, conference, constituting, contravening, cornerstone, cow, Cowan, Cowen, CR, crowded, cure, customary, Daniel, DAYTRANA, debilitating, decentralized, declaratory, Deed, deficiency, deficient, Delaware, delta, Department, destroy, diagnosed, diarrhoea, didanosine, die, difficulty, diffused, diploma, disability, disabled, disabling, disagreed, disputed, dissenting, dissolve, Dow, drop, drugsthat, duty, DYNEPO, EBITDA, EC, educational, efavirenz, ELAPRASE, elapsed, elderly, emtricitabine, encapsulation, encephalopathy, endorsed, endoscopic, enfuvirtide, enlarged, enlargement, epoetin, EPZICOM, equitable, ER, ERISA, EST, etodolac, evolve, exert, Fabry, false, Fast, flowsusing, foregone, FORTOVASE, frame, freight, frequent, FSP, furniture, Fusion, FUZEON, Gaucher, Geffken, genetic, Genzyme, geography, Gilbert, glucocerebrosidase, GMT, graft, Graham, greatly, Gude, hand, handling, heard, hearing, hedgesand, hematological, hemisphere, HGT, HIVID, HSBC, Hunter, idle, idursulfase, illegal, illustrated, impracticable, incidence, includingestimated, incurrence, Indemnity, indinavir, ineligible, inherited, instructed, instruction, integrase, interference, intermittent, intervene, inventorycharge, involuntary, IR, Israel, Israeli, Jonathan, Justice, KALETRA, Krona, landlord, landscape, Latin, leadership, Leerink, Leff, legacy, Liaison, LIBOR, linear, LODINE, lysosomal, mad, madeto, magnitude, mandatory, marrow, Matrix, McNeil, median, merchandise, Merrill, MESAVANCE, Mike, Miller, misleading, misrepresentation, misuse, MMX, Moorhead, MPS, Multi, multicurrency, Natcan, nelfinavir, nevirapine, NHS, niche, NNRTI, NORVIR, Novation, ofmarket, ofNew, onOctober, Orgamol, overdue, Passage, patch, Patrick, Pendergast, penetration, percent, perfect, Pfizer, Physical, PIs, pivotal, plaintiff, poll, precluded, prohibit, prohibitively, PSLRA, Psychiatry, PTO, purportedly, quadruple, quantum, quartile, Rabbi, radiation, ramp, Randolph, rare, ratethat, ratification, RAZADYNE, readilydeterminable, reassignment, receiptswere, Recherche, recognised, recouped, referencing, refinancing, refused, refute, regained, regime, regimen, regularly, reinfection, reinstate, reinstatement, rejected, remanded, REPLAGAL, replenish, reply, repudiate, residency, respond, retrospective, RETROVIR, revolving, REYATAZ, rheumatoid, Rhodia, ritonovir, rival, robust, Roche, Rodman, Royal, Safeguard, saquinavir, SCC, scorecard, Scotland, Selden, Senate, serum, settled, SG, SHGT, Shireplc, shortly, significantinfluence, situated, situation, sixteen, skin, Software, Solvay, SPARLON, SPG, spleen, spoilage, spongiform, SR, stamp, stavudine, Stipulation, Strasbourg, sudden, Sumitomo, sun, surviving, SUSTIVA, Swann, taxdeductible, Tel, tender, tendered, themarket, theremaining, thereto, thereunder, theventure, Tipranavir, TKT, Track, Transkaryotic, triple, TSR, tumour, Tyco, UCB, unaffected, underperformance, unlabeled, unopposed, Unresolved, unspecified, unwarranted, Upjohn, upper, User, UV, validly, valuereported, variance, vast, Vertex, VIDEX, VIRACEPT, VIRAMUNE, Virginia, voluntarily, voluntary, Walter, wasted, wereused, Western, winding, Wisconsin, withholding, wording, Xanodyne, XL, Yetter, zalcitabine, ZERIT, zidovudine
Removed:
AAH, acetate, analogue, assuming, Atlantic, attended, bipolar, bloodstream, Boehringer, breaching, BS, Bulletin, candidate, ceased, Celltech, clear, complement, composition, concept, conflicting, consented, conversion, curtail, daffodil, decide, dedicated, detailed, diluting, dilution, discontinuance, distributed, divestment, essentially, exercising, experienced, explore, extracted, favor, Fidelity, field, FMR, forced, functioned, graduate, Guilford, hypotension, indefinite, indefinitely, Ingelheim, initiative, innovative, intercompany, isomer, largely, leased, liquidation, LLC, marginally, mark, Matthey, menopause, merged, mixed, negotiation, Niro, occupied, opposed, orthostatic, OTC, owing, pooling, posture, predecessor, proamatine, producing, profound, proof, rapid, rationalize, recognizing, rectal, redeemable, reformulating, relinquish, remitted, reportable, resolve, retained, reuptake, selectively, shared, size, sNDA, SpA, spend, stand, succession, synthetic, terminal, terminate, Totten, treating, undergraduate, Unichem, upgrade, upright, Valley, Vicuron, viral, warehouse, washington, Wilson
Filing tables
Filing exhibits
Related press release
SHPG similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Shire plc’s Registration Statements on Form S-8 (Nos. 333-09168, 333-93543, 33-60952, 333-91552, 333-111579, 333-129961, 333-129960 and 333-111108), Form S-4 (No. 333-55696) and Form S-3 (Nos. 333-72862-01, 333-38662 and 333-39702) of our report dated March 1, 2006, relating to the financial statements and financial statement schedules of Shire plc and management's report on the effectiveness of internal control over financial reporting appearing in this Annual Report on Form 10-K of Shire plc for the year ended December 31, 2005.
/s/ Deloitte & Touche LLP |
DELOITTE & TOUCHE LLP |
Reading, England |
March 1, 2006 |